ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

ClinicalTrials.gov ID: NCT03953079

Public ClinicalTrials.gov record NCT03953079. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 3:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Multicenter Dose-Ranging Study Evaluating the Safety and Efficacy of Sunitinib Malate Depot Formulation (GB-102) Compared to Aflibercept in Subjects With Neovascular (Wet) Age-related Macular Degeneration (ALTISSIMO Study)

Study identification

NCT ID
NCT03953079
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Graybug Vision
Industry
Enrollment
56 participants

Conditions and interventions

Interventions

  • Aflibercept Drug
  • Drug: GB-102 Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 25, 2019
Primary completion
Dec 14, 2020
Completion
Jun 2, 2021
Last update posted
Jan 18, 2022

2019 – 2021

United States locations

U.S. sites
33
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Retinal Consultants AZ Gilbert Arizona 85296
Retinal Research Institute Phoenix Arizona 85017
California Retina Research Consultants Bakersfield California 93309
Retinal Diagnostic Center of Northern California Campbell California 95008
The Retina Partners Encino California 91436
Retina Consultants of Orange County Fullerton California 92835
Northern California Retina Vitreous Associates Medical Group, Inc. Mountain View California 94040
West Coast Retina Medical Group, Inc. San Francisco California 94109
California Retina Consultants - CRC Santa Barbara California 93103
Bay Area Retina Associates Walnut Creek California 94598
Specialty Retina Center Coral Springs Florida 32503
Florida Retina Institute Orlando Florida 32806-1101
Retina Specialty Institute Pensacola Florida 32503
Eye Associates of Pinellas Pinellas Park Florida 33782
Southeast Retina Center Augusta Georgia 30909
Retina Consultants of Hawaii ‘Aiea Hawaii 96701
University Retina and Macula Lemont Illinois 60439
Wolfe Eye Clinic - West Des Moines Des Moines Iowa 50266
Eye Associates of Northeast Louisiana West Monroe Louisiana 71291
Cumberland Valley Retina Consultants Hagerstown Maryland 21740
Mid Atlantic Retina Specialists Hagerstown Maryland 21740
Sierra Eye Associates Reno Nevada 89502
Ophthalmic Consultants of Long Island Oceanside New York 11572
Sterling Research Cincinnati Ohio 45219
Black Hills Regional Eye Institute Rapid City South Dakota 57701
Retina Research Institute of Texas Abilene Texas 79606
Austin Retina Associates Austin Texas 78705
Retina Research Center, PLLC Austin Texas 78705
Retina Specialists Plano Texas 75093
Retina Consultants of Houston The Woodlands Texas 77384
Strategic Clinical Research Group LLC Willow Park Texas 76087
Piedmont Eye Center Lynchburg Virginia 24502
Retina Center NW PLLC Silverdale Washington 98383

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03953079, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2022 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03953079 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →